Literature DB >> 17699369

Should dialysis patients ever receive warfarin and for what reasons?

William M Bennett1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17699369     DOI: 10.2215/CJN.01700506

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

2.  Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation.

Authors:  Claudio Musetti; Marco Quaglia; Tiziana Cena; Michele Battista; Roberta Fenoglio; Elisa Lazzarich; Piero Stratta
Journal:  J Nephrol       Date:  2015-03-06       Impact factor: 3.902

Review 4.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

5.  Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Amanda R Patrick; Soko Setoguchi; Niteesh K Choudhry
Journal:  J Nephrol       Date:  2012 May-Jun       Impact factor: 3.902

6.  Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.

Authors:  Jingwen Tan; Sunjae Bae; Jodi B Segal; Junya Zhu; Dorry L Segev; G Caleb Alexander; Mara McAdams-DeMarco
Journal:  J Nephrol       Date:  2017-01-24       Impact factor: 3.902

7.  Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.

Authors:  Jingwen Tan; Sunjae Bae; Jodi B Segal; Junya Zhu; G Caleb Alexander; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Nephrology (Carlton)       Date:  2019-02       Impact factor: 2.506

Review 8.  Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?

Authors:  Jenny I Shen; Mintu P Turakhia; Wolfgang C Winkelmayer
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-11       Impact factor: 2.894

9.  Kidney function influences warfarin responsiveness and hemorrhagic complications.

Authors:  Nita A Limdi; T Mark Beasley; Melissa F Baird; Joyce A Goldstein; Gerald McGwin; Donna K Arnett; Ronald T Acton; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

10.  Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation.

Authors:  Anat Bel-Ange; Shani Zilberman Itskovich; Liana Avivi; Kobi Stav; Shai Efrati; Ilia Beberashvili
Journal:  BMC Nephrol       Date:  2021-05-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.